Pharma Stock More Than Halved on Drug Trial Flop

More analysts could cut their price targets on plummeting ACIU

Digital Content Manager
Jan 30, 2019 at 10:16 AM
facebook X logo linkedin

The shares of AC Immune SA (NASDAQ:ACIU) are down 68.3% at $3.40, after the company and partner Roche said they're halting late-stage trials of Alzheimer's drug crenezumab. The medical research concern said the drug would likely fail to meet its primary goal. ACIU stock is now plumbing new record lows -- dropping to $3.34 earlier -- and on pace for its worst day ever.

Prior to today, AC Immune shares had been struggling to overtake the $12 area, which is about a 50% Fibonacci retracement from the equity's mid-July peak above $17.40 to its early October lows around $7. The security had been bouncing off the $8 area in recent months, but is trading well below that level today.

In response to today's news, Jefferies cut its price target to $18 from $32. Leerink, meanwhile, slashed its ACIU price target to $11 from $18. However, both new targets still represent steep upside for the shares from current levels.

Other analysts could follow that lead, too, with the stock currently sporting two "strong buy" ratings and one "buy," with not a single "hold" or "sell" in sight. Plus, the consensus 12-month target price of $17.50 -- an area ACIU hasn't hit since it first began trading in 2016 -- represents a whopping 422% premium to current levels. Should ACIU continue to struggle, a round of potential downgrades and additional price-target cuts could translate into more headwinds. 


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI